Radiation Therapy, Plasma Exchange, and Immunotherapy (Pembrolizumab or Nivolumab) for the Treatment of Melanoma

NCT04581382 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Melanoma

Interventions

BIOLOGICAL: Nivolumab
BIOLOGICAL: Pembrolizumab
RADIATION: Radiation Therapy
BIOLOGICAL: Therapeutic Exchange Plasma
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
PROCEDURE: Positron Emission Tomography
PROCEDURE: Magnetic Resonance Imaging

Sponsor

Mayo Clinic

Collaborators

[object Object]